Description
Generic name: Fenofibrate/Pravastatin
Packing: 3O caps 40mg each
Pravafenix is indicated for the treatment of high-coronary-heart-disease (CHD)-risk adult patients with mixed dyslipidaemia characterised by high triglycerides and low HDL-cholesterol (C) levels whose LDL-C levels are adequately controlled while on a treatment with pravastatin-40-mg monotherapy.
Reviews
There are no reviews yet.